U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07948070) titled 'A Phase I/II Open-label Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Rejuvenated Tumor-Reactive T Cells (GKPTZ-01) in Subjects With Pancreatic Cancer' on Nov. 13.

Brief Summary: A Phase I/II Open-label Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of Rejuvenated Tumor-Reactive T Cells (GKPTZ-01) in Subjects with Pancreatic Cancer

Study Start Date: June 02

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: DRUG: GKPTZ-01 in Combination with Adjuvant Chemotherapy

Combination with Adjuvant Chemotherapy

DRUG: GKPTZ-01

GKPTZ-01

DRUG: GKPTZ-01 in Combin...